文献速递儿童感染儿童血液肿瘤与免疫

2007-2014年美国癌症患儿发热伴中性粒细胞减少住院趋势

National Trends in Hospitalization for Fever and Neutropenia in Children with Cancer, 2007-2014.
PubMed 文献 · J Pediatr · 2018-07-17

OBJECTIVE: To assess the trends of inpatient resource use and mortality in pediatric hospitalizations for fever with neutropenia in the US from 2007 to 2014.…

要点

  • 发热伴中性粒细胞减少住院数、住院时长与费用在2007-2014年间均显著上升。
  • 总体院内死亡率低(0.75%),但15-19岁年龄组死亡风险显著更高。
  • 脓毒症、肺炎、脑膜炎和真菌感染为死亡风险较高的合并症。

核心结论

  • 2007-2014年美国儿童癌症发热伴中性粒细胞减少住院的例数、住院时长和费用均上升,总体死亡率低但青少年死亡风险更高。
  • 作者建议开展标准化风险分层和成本效益治疗策略研究,并关注青少年癌症患者的较高死亡率。

研究设计与样本

  • 基于美国全国住院患者样本(NIS)及国际疾病分类第九版临床修订(ICD-9-CM)编码,分析2007-2014年儿童癌症发热伴中性粒细胞减少住院。
  • 对每例NIS出院记录加权,估算中位费用、住院时长和院内死亡率。

主要发现

  • 加权住院数从2007年每10万美国人口12.9升至2014年18.1。
  • 5-14岁年龄组、男性、所有种族及美国中西部和西部医院区域住院趋势显著上升。
  • 总体死亡率0.75%,15-19岁组死亡风险显著更高(OR 2.23,95%CI 1.36-3.68,P=.002)。

关键数值与推荐

  • 脓毒症、肺炎、脑膜炎和真菌感染为发热伴中性粒细胞减少住院期间死亡风险较高的合并症。
  • 15-19岁年龄组院内死亡风险OR 2.23(95%CI 1.36-3.68,P=.002)。

临床怎么用

  • 儿科医生应关注癌症发热伴中性粒细胞减少患儿的住院资源使用上升趋势及青少年较高的死亡风险。
  • 对合并脓毒症、肺炎、脑膜炎或真菌感染的患者需警惕更高死亡风险。

局限性

  • 研究为基于行政编码数据库的回顾性分析,原文未报告编码准确性等具体局限细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the trends of inpatient resource use and mortality in pediatric hospitalizations for fever with neutropenia in the US from 2007 to 2014. STUDY DESIGN: Using National (Nationwide) Inpatient Sample (NIS) and International Classification of Diseases, Ninth Revision, Clinical Modification codes, we studied pediatric cancer hospitalizations with fever with neutropenia between 2007 and 2014. Using appropriate weights for each NIS discharge, we created national estimates of median cost, length of stay, and in-hospital mortality rates. RESULTS: Between 2007 and 2014, there were 104 315 hospitalizations for pediatric fever with neutropenia. The number of weighted fever with neutropenia hospitalizations increased from 12.9 (2007) to 18.1 (2014) per 100 000 US population. A significant increase in fever with neutropenia hospitalizations trend was seen in the 5- to 14-year age group, male sex, all races, and in Midwest and Western US hospital regions. Overall mortality rate remained low at 0.75%, and the 15- to 19-year age group was at significantly greater risk of mortality (OR 2.23, 95% CI 1.36-3.68, P = .002). Sepsis, pneumonia, meningitis, and mycosis were the comorbidities with greater risk of mortality during fever with neutropenia hospitalizations. Median length of stay (2007: 4 days, 2014: 5 days, P < .001) and cost of hospitalization (2007: $8771, 2014: $11 202, P < .001) also significantly increased during the study period. CONCLUSIONS: Our study provides information regarding inpatient use associated with fever with neutropenia in pediatric hospitalizations. Continued research is needed to develop standardized risk stratification and cost-effective treatment strategies for fever with neutropenia hospitalizations considering increasing costs reported in our study. Future studies also are needed to address the greater observed mortality in adolescents with cancer.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Lekshminarayanan A, Bhatt P, Linga VG, et al. National Trends in Hospitalization for Fever and Neutropenia in Children with Cancer, 2007-2014. J Pediatr. 2018. PMID: 30029861. doi:10.1016/j.jpeds.2018.06.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。